FDA Import Refusal AMN-0103137-2/232/1S — Balaxi Healthcare Honduras, S De R.L.
The FDA refused shipment AMN-0103137-2/232/1S from Balaxi Healthcare Honduras, S De R.L. (Honduras) on May 14, 2025. The refused product falls under Drugs and Biologics — DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal details
- Date
- May 14, 2025
- Country
- Honduras
- Product Category
- Drugs and Biologics
- Product Code
- 62GBY90 DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY)
- Charges
- 75